Safety concerns : Important risks associated with GLP-1 receptor agonists include pancreatitis, gallbladder disease, dehydration leading to acute kidney injury, hypoglycaemia (when used with insulin or sulfonylureas), and potential worsening of diabetic retinopathy with rapid glycaemic improvement
Powerful antioxidant & anti-inflammatory support -Curcumin and BetaGlucan defend against free radicals, soothe inflammation and promote skin recovery
This pain can range from mild to severe and may lead to pancreatitis in some cases
The difference between 2.5mg and 5mg of tirzepatide produces meaningfully different outcomes
Other Ingredients: Clacium Carbonate, stearic acid, croscarmellose sodium, hydroxpropyl cellulose, magnesium stearate, silica, and coating (Hypromellose, and glycerin)
Targeting inflammation and necroptosis in diabetic kidney disease: a novel approach via PPAR modulation